Physician profile
Saiful Kabir
NPI 1598766321
$3,304.45
in general payments reported to CMS, 2019-2025
43 companies · $748 in 2025
The $748 reported for 2025 was more than what a typical Pulmonary Disease provider received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,049 · 2020: $272 · 2021: $71.61 · 2022: $260 · 2023: $462 · 2024: $442 · 2025: $748.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,564 · Education: $87.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,564.25 |
| Education | $87.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $551.97 | 2019-2025 | Nucala, Trelegy Ellipta, Arexvy |
| Astrazeneca Pharmaceuticals LP | $482.05 | 2019-2025 | Fasenra, Tezspire, Breztri |
| Boehringer Ingelheim Pharmaceuticals, INC. | $283.64 | 2019-2025 | Ofev, Jascayd |
| Regeneron Healthcare Solutions, INC. | $244.18 | 2019-2025 | Dupixent |
| Genzyme Corporation | $204.34 | 2020-2025 | |
| Takeda Pharmaceuticals U.S.A., INC. | $202.99 | 2020-2025 | Glassia |
| Harmony Biosciences LLC | $128.86 | 2025 | |
| Genentech USA, INC. | $98.57 | 2019-2020 | |
| Insmed, INC. | $96.06 | 2019-2025 | Arikayce, Brinsupri |
| Amgen INC. | $73.08 | 2023-2024 | Tezspire |
| Electromed, INC. | $68.22 | 2019-2025 | Smartvest |
| Philips North America LLC | $66.91 | 2019-2025 | Vest Therapy Und |
| Janssen Pharmaceuticals, INC | $58.49 | 2019-2020 | |
| United Therapeutics Corporation | $57.98 | 2019-2023 | Tyvaso |
| Inspire Medical Systems, INC. | $51.67 | 2025 | Inspire |
Show all 43 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Saiful Kabir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.